The George Institute for Global Health Overview
- Year Founded
-
1999
- Status
-
Private
- Employees
-
700
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$22M
- Investors
-
4
The George Institute for Global Health General Information
Description
Operator of a for-profit global healthcare firm intended to deliver affordable, scalable treatments and technologies. The company focuses on the late-stage clinical development of medicines and treatments by combining established drugs in innovative fixed-dose formulations for patients with cardiometabolic diseases, such as heart disease, hypertension, and diabetes, enabling the healthcare industry to provide treatments that are more efficacious, safer, and affordable than current alternatives.
Contact Information
Website
www.georgeinstitute.orgCorporate Office
- Level 8, Health Translation Hub
- 55 Botany Street, Randwick
- Sydney, New South Wales 2031
- Australia
Corporate Office
- Level 8, Health Translation Hub
- 55 Botany Street, Randwick
- Sydney, New South Wales 2031
- Australia
The George Institute for Global Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 10-Mar-2020 | $22M | Completed | Generating Revenue | ||
| 1. Grant | 01-Jan-2013 | Completed | Startup |
The George Institute for Global Health Comparisons
Industry
Financing
Details
The George Institute for Global Health Competitors (3)
One of The George Institute for Global Health’s 3 competitors is Glenmark Farmacêutica, a Corporation company based in Sao Paulo, Brazil.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Glenmark Farmacêutica | Corporation | Sao Paulo, Brazil | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain |
The George Institute for Global Health Signals
The George Institute for Global Health Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Brandon Capital | Venture Capital | Minority | ||
| Bupa HI | Corporation | Minority | ||
| Federation Asset Management | PE/Buyout | Minority | ||
| National Health and Medical Research Council | Government |
The George Institute for Global Health Investments (9)
The George Institute for Global Health’s most recent deal was a Accelerator/Incubator with Roam Technologies for . The deal was made on 20-Oct-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Roam Technologies | 20-Oct-2025 | Accelerator/Incubator | Other Devices and Supplies | ||
| GonGlobal | 10-Oct-2024 | Accelerator/Incubator | Biotechnology | ||
| Gheorg | 26-Oct-2023 | Accelerator/Incubator | Clinics/Outpatient Services | ||
| NeoGenix Biosciences | 09-Jan-2023 | Accelerator/Incubator | Other Healthcare Technology Systems | ||
| Resonait | 22-Nov-2022 | Accelerator/Incubator | Therapeutic Devices |
The George Institute for Global Health FAQs
-
When was The George Institute for Global Health founded?
The George Institute for Global Health was founded in 1999.
-
Where is The George Institute for Global Health headquartered?
The George Institute for Global Health is headquartered in Sydney, Australia.
-
What is the size of The George Institute for Global Health?
The George Institute for Global Health has 700 total employees.
-
What industry is The George Institute for Global Health in?
The George Institute for Global Health’s primary industry is Clinics/Outpatient Services.
-
Is The George Institute for Global Health a private or public company?
The George Institute for Global Health is a Private company.
-
What is The George Institute for Global Health’s current revenue?
The current revenue for The George Institute for Global Health is .
-
How much funding has The George Institute for Global Health raised over time?
The George Institute for Global Health has raised $22M.
-
Who are The George Institute for Global Health’s investors?
Brandon Capital, Bupa HI, Federation Asset Management, and National Health and Medical Research Council have invested in The George Institute for Global Health.
-
Who are The George Institute for Global Health’s competitors?
Glenmark Farmacêutica, Intas Pharmaceuticals, and Ability Pharma are competitors of The George Institute for Global Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process